Our Blog

Oxford Immune Algorithmics, the

Oxford Immune Algorithmics (OIA),

Oxford Immune Algorithmics (OIA), the

Oxford Immune Algorithmics (OIA), the

The Canadian College of

Oxford Immune Algorithmics (OIA)

Oxford Immune Algorithmics recently participated in the 41st GITEX Global event hosted at the Dubai World Trade Centre in Dubai, UAE.

Oxford Immune Algorithmics, growing by leaps and bounds, recently announced the appointment of Mr. Tony Cambridge to its Scientific Advisory Board.

Oxford Immune Algorithmics is proud to announce the appointment of internationally recognised innovator, Dr. Corey Cutler, to its Scientific Advisory Board.

An exceptional experience was planned for a select group of tech Startup founders last week in London. The Founder’s Forum & Mubadala Capital Ventures hosted a special Founder’s Forum event celebrating London’s Tech Week.

The mission of MBZUAI is to be the hub of fundamental AI research, training and transformation, and the global epicentre of research in the field. It is the world’s first university committed to AI, which makes the MBZUAI a perfect partner.

The UK’s Departament of International Trade recently announced the selection of Oxford Immune Algorithmics (OIA) as one of the health-tech companies that will participate in the UK’s Health Technology Showcase at Expo 2020.

The Alan Turing Institute, based in London, has appointed OIA’s Founder and CEO, Dr Hector Zenil, as a senior researcher and policy advisor on Artificial Intelligence for Scientific Discovery.

Oxford Immune Algorithmics (OIA), creator of the Algocyte health-tech venture, has officially graduated from the Class No. 11 German-based SpinLab accelerator.

Oxford Immune Algorithmics’ trajectory as a Medtech and Biotech company continues to accelerate. The award-winning company recently announced the appointment of pioneering…

We are proud to announce that Oxford Immune Algorithmics (OIA), creator of Algocyte, is part of  the Creative Destruction Lab-Toronto Health Diagnostics Stream’s 2020/21 graduating cohort…

Oxford Immune Algorithmics’ (OIA) continues to be acknowledged both internationally and in the U.K. The recent announcement of the award of…

Oxford Immune Algorithmics (OIA) has been announced the winner of Etihad’s AI international competition. Etihad Group Finance, owner of award-winning Abu Dhabi-based Etihad Airlines…

OIA’s flagship AI Medical Assistant, Algocyte, will be integrated into MyGlobalHome’s digital health ecosystem, allowing users to complete personal blood tests remotely at will…

Drawing on more than a decade of research in computational biology and systems medicine conducted at institutions such as the the University of Oxford…

Oxford Immune Algorithmics (OIA) is honoured to announce a new partnership with a major university in the UAE, Khawarizmi International College or KIC, made possible by Dr Assem Al-Hajj…

Co-founder and CTO, Dr. Jürgen Riedel, is interviewed by Founderella

SpinLab, one of the best-ranked accelerating programmes in Europe based in Leipzig, Germany, has selected a handful of startups out of hundreds of applications, including OIA, to be supported and introduced…

Supported by HUB71, a new subsidiary of OIA, Immune Algorithmics Middle East Ltd, has officially started operations and opened an office in Abu Dhabi.

OIA has been accepted into the ‘CDL-recovery’ programme in Atlanta, U.S. with the purpose to explore the U.S. market and contribute to the world recovery during and after COVID-19.

Most global healthcare resources are focused on COVID19 and this is largely disrupting the continuum of care for patients with chronic diseases (Chudasama et al., 2020).

Algocyte is helping change how frequently and where people are monitored and get tested, but most people (89%) are still at high risk of infection from travelling…

IA’s CTO Dr. Jürgen Riedel and Senior AI Researcher Dr. Santiago Hernández-Orozco delivered an invited technical talk at the international conference AUTOMATA 2020, the 26th International Workshop on Cellular…

AUTOMATA 2020 will focus on the theory and applications that many of OIA’s own proprietary methods are based upon, on the deep connections of discrete dynamical systems complexity…

We are thrilled to announce that Oxford Immune Algorithmics signed last week a collaboration and commercial agreement with the National Health Service in the UK to serve and continue co-developing Algocyte®

mune Algorithmics has been nominated to the OBN awards for the Best Start-up Medtech in the UK. The awards celebrate outstanding achievement throughout the life sciences industry. 

OIA has become a sponsor and will join CogX 2020 as an exhibitor with a dedicated virtual booth. CogX is the Festival of AI and Emerging Technology and will take place on the 8th-10th June 2020.

OIA’s Chief Medical Officer, Dr. Kourosh Saeb-Parsy, offers an inspiring introduction to the clinical need for Algocyte and how it could help save lives.

The FQXi catalyses, supports, and disseminates research on questions at the foundations of physics, particularly new frontiers and innovative ideas integral to a deep understanding of reality. 

Our CEO, Dr. Hector Zenil, will be delivering the opening Keynote at the Predictive Analytics World summit on May 11, 2020 originally planned to be held in Munich, Germany but now to be held online.

announcement introducing Project Lancelot, OIA and Algocyte’s response to Covid-19…

We have successfully closed our latest funding round with SFC and KIN Capital leading it, award winning investors, both joining last week our multinational shareholder’s board supporting OIA.

According to the organisers, STHLM TECH is the largest startup event in Europe where every geek, hacker, entrepreneur, investor, and designer around Stockholm comes together under one roof.

Oxford Immune Algorithmics (OIA), like almost every other company and organisation around the world is putting in place contingency plans to downsize operations…

Oxford Immune Algorithmics (OIA) has been chosen one of 50 game-changers in the Thames Valley (UK’s Silicon Valley) for the creation of Algocyte and our responsible AI approaches…

We have published our first paper to introduce the novel numerical and colour-based risk stratification score available throughour Algocyte® 

With over 1000 attendants at London’s largest event venue, the Excel, the sold-out Intelligent Health 2020 event was a success and OIA/Algocyte was one of the featured…

Oxford Immune Algorithmics (OIA) is very proud to have partnered with the University of Reading and welcomes two of their students in Computer Science hired with the partial support of the University of Reading…

We are very excited to share the announcement that we have accomplished a major milestone getting Algocyte® certified under the European Commission medical device directive.

OIA will be exhibiting at one of the world’s leading summits on AI in medicine, Intelligent Health 2020 on 5 February 2020 at a prime venue, the ExCel, London, U.K. where we will be promoting Algocyte, our flagship product for end-to-end remote blood testing…

Promoted and streamed online worldwide and to the Austin Vita offices in Germany and the U.S., as advertised locally in Reading’s giant screen at the train station, six speakers welcomed 80 attendants

Bringing people interested in closing the gap between academia and industry together, and in cutting-edge science and technology solutions, we at Oxford Immune Algorithmics with Austin Fraser and…

Organised in partnership with the NHSx, Intelligent Health UK is the World’s Leading AI in Medicine Summit, 5 February 2020 | London | UK

OIA’s first anniversary was this past September 25th and the University of Oxford planted a 4-year old beech tree in honour of Oxford Immune Algorithmics (OIA) at the Oxford University premises in Wytham…

OIA will be at the the early stage life sciences investment event to be held at Level39 in Canary Wharf, London, January 20, 2020.

On the 15-16 October 2019, OIA is attending The Global Innovation and New Technology Health Event at the Chelsea Football Club Stadium in London where it is showcased the leading health tech startups from around the world.

An application of our research in causal models in molecular biology has been published today in one of the finest journals in molecular biology, Nucleic Acids Research (Oxford).

We have been growing at an exciting rate and we have moved offices three times already only this year. We have now opened our new AI-biomedical lab this month and we are already thinking of expanding it.

To Better Deal With Causality In Molecular Biology & Immunology To Make A Real Impact In The Future Of Healthcare

We are heading to #TuringFest19 in Edinburgh this August. OIA has been invited to participate in the Turing Founders event where startups and new companies meet investors.

OIA has been invited as a VIP guest to the 3rd annual In-Memory Computing Summit Europe, on June 3 & 4, at the Park Plaza Victoria in London where we will be promoting our science and technology. 

We were invited to introduce OIA and present our work on AI for healthcare at the Thames Valley Artificial Intelligence meetup organised by Barclays AI Frenzy and Innovation Catalyst, University of Reading.

At Oxford Immune Algorithmics (OIA) we firmly believe that it is our obligation to do our best to promote the use of the most advanced scientific and technological tools and methods  currently available in the fight against human disease.

A three day festival of events on 10-12 June, 2019.

Invited by the organisers, Dr. Zenil (CEO) presented our research on AI for medicine at the World Expo on AI, Big Data & IoT at the Olympia Exhibition Centre on the 25th April in London, U.K.

Signed by Oxford Immune Algorithmics, these two new papers show how we are trying to transform healthcare with science technology.